Profiel
Michael A. Jacobsen formerly worked at ICOS Corp., as Senior Director-Finance & Corporate Controller, Sarepta Therapeutics, Inc., as Secretary, Chief Accounting Officer & VP-Finance from 2012 to 2013, ZymoGenetics, Inc., as Chief Accounting Officer & Vice President from 2007 to 2011, and Omeros Corp., as Chief Accounting Officer, Treasurer & VP from 2013 to 2024.
Mr. Jacobsen received his undergraduate degree in 1980 from Idaho State University.
Eerdere bekende functies van Michael Jacobsen
| Bedrijven | Functie | Einde |
|---|---|---|
| OMEROS CORPORATION | Financieel Directeur/CFO | 30-06-2024 |
| SAREPTA THERAPEUTICS, INC. | Financieel Directeur/CFO | 15-11-2011 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Operationeel Directeur | 01-08-2011 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Financieel Directeur/CFO | - |
Opleiding van Michael Jacobsen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Omeros Corp.
Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Idaho State University
Idaho State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















